Rubric Capital Management LP 13D and 13G filings for Karyopharm Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 06:06 am Sale |
2023-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Rubric Capital Management LP | 0 0.000% |
-552,975 (Position Closed) |
Filing |
| 2023-02-10 4:00 pm Purchase |
2022-12-31 | 13G | Karyopharm Therapeutics Inc. KPTI |
Rubric Capital Management LP | 552,975 7.330% |
552,975 (New Position) |
Filing |